![](/img/cover-not-exists.png)
614TiPUCGI 28 Panirinox: A randomized phase II study assessing Panitumumab + FOLFIRINOX or mFOLFOX6 in RAS and BRAF wild type metastatic colorectal cancer patients (mCRC) selected from circulating DNA analysis
Mazard, T, Ghiringhelli, F, Mollevi, C, Assenat, E, Gavoille, C, Smith, D, Pezzella, V, Meddeb, R, Pastor, B, Ychou, M, Thierry, A RVolume:
29
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy281.159
Date:
October, 2018
File:
PDF, 83 KB
2018